ACADIA PHARMACEUTICALS INC. Other Non-Current Liabilities
ACADIA PHARMACEUTICALS INC. (ACAD) had Other Non-Current Liabilities of $15.31 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $15.31M.
- 2026-03-31: Other Liabilities, Noncurrent $12.64M.
- 2025-12-31: Other Liabilities, Noncurrent $19.14M.
- 2025-09-30: Other Liabilities, Noncurrent $13.89M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $15.31M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $12.64M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $19.14M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $13.89M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $28.55M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $19.96M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $18.06M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $12.36M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $11.27M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $15.15M 10-K · filed 2025-02-27 |
| 2023-09-30 | $12.66M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $9.26M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.30M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $9.07M 10-K · filed 2024-02-28 |
| 2022-09-30 | $6.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $5.54M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.37M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.03M 10-K · filed 2023-02-28 |
| 2021-09-30 | $4.82M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.13M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.61M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.18M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.60M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $4.54M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.24M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.86M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.17M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.01M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $1.56M 10-K · filed 2020-02-27 |
| 2011-09-30 | $28.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $60.00K 10-Q · filed 2011-08-10 |
| 2010-12-31 | $124.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |